One of the latest executive orders signed by Joe Biden prohibits these infrastructures from being built in areas with a high ...

Discover how explainable AI (xAI) and real-world data (RWD) improve clinical decision-making in oncology by identifying key prognostic markers across multiple cancer types.

Fewer people than before are being diagnosed with and dying from cancer in Appalachia, but cancer incidence and death rates remain substantially higher, especially in certain areas of Central ...

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images.

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Fewer people than before are being diagnosed with and dying from cancer in Appalachia, but cancer incidence and death rates ...

Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...

One of the most agonizing experiences a cancer patient suffers is waiting without knowing: waiting for a diagnosis, waiting ...

Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...

A new state dashboard lets policymakers across Kansas see mortality rates, risk factors and other detailed data about cancer in their communities, and it has good news and bad news about the disease ...

Co-corresponding authors of the Cancer Discovery paper on the St. Jude survivorship portal (L to R): Xin Zhou, PhD, Jinghui Zhang, PhD, and Yutaka Yasui, PhD. Photo courtesy of ...

The research team led by Professor Kwang-Hyun Cho of KAIST Bio and Brain Engineering who recently announce "Cancer Reversion ...